Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-011053
Filing Date
2025-05-15
Accepted
2025-05-15 17:00:26
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 755085
2 EX-10.2 ex10-2.htm EX-10.2 48037
3 EX-10.3 ex10-3.htm EX-10.3 82915
4 EX-31.1 ex31-1.htm EX-31.1 17849
5 EX-31.2 ex31-2.htm EX-31.2 17668
6 EX-32.1 ex32-1.htm EX-32.1 6907
7 EX-32.2 ex32-2.htm EX-32.2 7195
  Complete submission text file 0001641172-25-011053.txt   4072312

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE celc-20250331.xsd EX-101.SCH 27748
9 XBRL CALCULATION FILE celc-20250331_cal.xml EX-101.CAL 42431
10 XBRL DEFINITION FILE celc-20250331_def.xml EX-101.DEF 104397
11 XBRL LABEL FILE celc-20250331_lab.xml EX-101.LAB 296848
12 XBRL PRESENTATION FILE celc-20250331_pre.xml EX-101.PRE 220923
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 490482
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38207 | Film No.: 25955096
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)